|
A more recent version of this article appeared on April 1, 2003
Papers In Press, published online ahead of print January 16, 2003
J. Lipid Res., doi:10.1194/jlr.M200339-JLR200
Submitted on August 25, 2002
Revised on January 16, 2003
Accepted on January 7, 2003
HDL regulates the displacement of hepatic lipase from cell surface proteoglycans and the hydrolysis of VLDL triacylglycerol
Tanya A. Ramsamy, Jonathan Boucher, Robert J. Brown, Zemin Yao, and Daniel L. Sparks
University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7
Corresponding Author: dsparks{at}ottawaheart.ca
We have previously shown that hepatic lipase (HL) is inactive when bound to purified heparan sulfate proteoglycans and can be liberated by HDL and apolipoproteinA-I (apoA-I), but not by LDL or VLDL. In this study, we show that HDL is also able to displace HL directly from the surface of the hepatoma cell line, HepG2, and Chinese Hamster Ovary cells stably overexpressing human HL. ApoA-I is more efficient at displacing cell surface HL than is HDL and different HDL classes vary in their ability to displace HL from the cell surface. HDL2 have a greater capacity to remove HL from the cell surface and intracellular compartments as compared to the smaller HDL particles. The different HDL subclasses also uniquely affect the activity of the enzyme. HDL2 stimulates HL mediated hydrolysis of VLDL-TG, while HDL3 is inhibitory. Inhibition of VLDL hydrolysis appears to result from a decreased interlipoprotein shuttling of HL between VLDL and the smaller more dense HDL particles. The study suggests that high HDL2 levels are positively related to efficient TG hydrolysis by their ability to enhance the liberation of HL into the plasma compartment and by a direct stimulation of VLDL-TG hydrolysis.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. K. Young, C. Chatterjee, and D. L. Sparks
HDL-ApoE Content Regulates the Displacement of Hepatic Lipase from Cell Surface Proteoglycans
Am. J. Pathol.,
July 1, 2009;
175(1):
448 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Curtiss, D. T. Valenta, N. J. Hime, and K.-A. Rye
What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport?
Arterioscler Thromb Vasc Biol,
January 1, 2006;
26(1):
12 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Brown, A. Gauthier, R. J. Parks, R. McPherson, D. L. Sparks, J. R. Schultz, and Z. Yao
Severe Hypoalphalipoproteinemia in Mice Expressing Human Hepatic Lipase Deficient in Binding to Heparan Sulfate Proteoglycan
J. Biol. Chem.,
October 8, 2004;
279(41):
42403 - 42409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Boucher, T. A. Ramsamy, S. Braschi, D. Sahoo, T. A-M. Neville, and D. L. Sparks
Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity
J. Lipid Res.,
May 1, 2004;
45(5):
849 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Galan, J. Peinado-Onsurbe, J. Julve, D. Ricart-Jane, M. Q. Robert, M. Llobera, and I. Ramirez
Inactive hepatic lipase in rat plasma
J. Lipid Res.,
December 1, 2003;
44(12):
2250 - 2256.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|